Log in to save to my catalogue

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4854513

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

About this item

Full title

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

Publisher

Japan: John Wiley & Sons, Inc

Journal title

Journal of diabetes investigation, 2016-04, Vol.7 (S1), p.102-109

Language

English

Formats

Publication information

Publisher

Japan: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Type 2 diabetes in East Asians is characterized primarily by β‐cell dysfunction, and with less adiposity and less insulin resistance compared with that in Caucasians. Such pathophysiological differences can determine the appropriate therapeutics for the disease. Incretins, glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1, ar...

Alternative Titles

Full title

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4854513

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4854513

Other Identifiers

ISSN

2040-1116

E-ISSN

2040-1124

DOI

10.1111/jdi.12490

How to access this item